This company has been marked as potentially delisted and may not be actively trading. LAVA Therapeutics (LAVA) News Today Add Share Share Headlines Stock AnalysisBuy This Stock LAVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Lava Therapeutics expects $1M of expenses related to restructuring planMarch 28, 2025 | markets.businessinsider.comJMP Securities Sticks to Its Hold Rating for LAVA Therapeutics (LVTX)March 28, 2025 | markets.businessinsider.comLAVA Therapeutics NV Reports Q4 2024 EPS of -0.30, Revenue of $2. ...March 28, 2025 | gurufocus.comHC Wainwright & Co. Downgrades LAVA Therapeutics N.V. (LVTX)February 28, 2025 | msn.comLava Therapeutics downgraded to Neutral from Buy at H.C. WainwrightFebruary 27, 2025 | markets.businessinsider.comLAVA Therapeutics N.V.: LAVA Announces Evaluation of Strategic OptionsFebruary 25, 2025 | finanznachrichten.deLAVA Announces Evaluation of Strategic OptionsFebruary 25, 2025 | finance.yahoo.comLava Therapeutics implements restructuring plan, workforce reduction of 30%February 25, 2025 | markets.businessinsider.comLVTX stock touches 52-week low at $0.88 amid market challengesFebruary 12, 2025 | msn.comGamma Delta T Cell Cancer Therapy Clinical Trials OverviewJanuary 29, 2025 | finance.yahoo.comJMP Securities Downgrades LAVA Therapeutics N.V. (LVTX)December 12, 2024 | msn.comLAVA Therapeutics N.V.: LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027December 10, 2024 | finanznachrichten.deKling Biotherapeutics Strengthens Leadership Team to Advance Pipeline Using its Proprietary Primary B-Cell Selection and Evolution PlatformDecember 10, 2024 | ca.finance.yahoo.comLava Therapeutics reports Q3 EPS (46c) vs (34c) last yearDecember 10, 2024 | markets.businessinsider.com10 New Pieces of Echoes of Wisdom Lore Zelda Fans Need to KnowOctober 14, 2024 | msn.comGoron Race Guide for Zelda: Echoes of WisdomOctober 12, 2024 | msn.comThe Legend of Zelda: Echoes of Wisdom - 10 Best Echoes For TraversalSeptember 29, 2024 | msn.comHow To Restore The Eldin Volcano Temple Rift In The Legend Of Zelda: Echoes Of WisdomSeptember 27, 2024 | msn.comThe Legend of Zelda: Echoes of Wisdom review – top-down magic reinvented for the betterSeptember 25, 2024 | mirror.co.ukMThe Legend of Zelda: Echoes of Wisdom review – "A refreshing, magic-filled retool of the Link's Awakening engine"September 25, 2024 | msn.comLAVA Therapeutics N.V.: LAVA Reports Second Quarter 2024 Financial Results and Business UpdateAugust 20, 2024 | finanznachrichten.deTake a tour of Hyrule in the new Legend of Zelda: Echoes of Wisdom trailerAugust 6, 2024 | msn.comNew trailer for The Legend of Zelda: Echoes of Wisdom arrivesAugust 6, 2024 | msn.comZelda’s big adventure gets a new trailerAugust 6, 2024 | msn.comThe 14 best Zelda-likes to play after Tears of the KingdomJuly 23, 2024 | msn.comZelda: Tears Of The Kingdom Goron City LocationMay 29, 2024 | msn.comLAVA Therapeutics N.V.: LAVA Provides Business Updates and Reports First Quarter 2024 Financial ResultsMay 21, 2024 | finanznachrichten.deLVTX Stock Earnings: LAVA Therapeutics Beats EPS, Misses Revenue for Q1 2024May 21, 2024 | msn.comStrong Buy Rating for LAVA Therapeutics on Promising Clinical and Financial OutlookMarch 21, 2024 | markets.businessinsider.comLAVA Therapeutics Full Year 2023 Earnings: Revenues DisappointMarch 21, 2024 | uk.finance.yahoo.comLVTX Stock Earnings: LAVA Therapeutics Misses EPS, Misses Revenue for Q4 2023March 20, 2024 | investorplace.comLiverpool XI vs Manchester United: Starting lineup, confirmed team news, injury latest for FA Cup todayMarch 17, 2024 | msn.comLVTX Apr 2024 2.500 callMarch 16, 2024 | finance.yahoo.comLAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)March 5, 2024 | finance.yahoo.comPRGS, EVER and LVTX are among after hour moversFebruary 26, 2024 | seekingalpha.comStrong Buy Rating for LAVA Therapeutics Amid Strategic Partnerships and Promising Clinical AdvancementsFebruary 2, 2024 | markets.businessinsider.comWhy Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJanuary 25, 2024 | msn.comDow Surges Over 100 Points; US GDP Growth Tops EstimatesJanuary 25, 2024 | benzinga.comWhy Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today?January 25, 2024 | msn.comNew Alzheimer’s Treatment Accelerates Removal of Plaque From The Brain In Clinical TrialsJanuary 15, 2024 | msn.comPsychedelics gave terminal patients relief from their intense anxietyJanuary 13, 2024 | msn.comAnalysts Are Bullish on These Healthcare Stocks: Genelux Corp. (GNLX), Calliditas Therapeutics (CALT)November 27, 2023 | markets.businessinsider.comLAVA Therapeutics N.V.: Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial ResultsNovember 16, 2023 | finanznachrichten.deMemo Therapeutics AG Appoints Erik van den Berg as Chief Executive OfficerNovember 16, 2023 | businesswire.comLAVA Therapeutics GAAP EPS of -$0.34 beats by $0.14November 16, 2023 | msn.comLava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial ResultsNovember 16, 2023 | finance.yahoo.comK36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical OfficerNovember 15, 2023 | finance.yahoo.comAnalysts Are Bullish on These Healthcare Stocks: US Physical Therapy (USPH), Calliditas Therapeutics (CALT)September 21, 2023 | markets.businessinsider.comDelveInsight Highlights Major Advances, Transformative Therapies, and 55+ Leading Players Wheeling the Chronic Lymphocytic Leukemia Pipeline LandscapeSeptember 18, 2023 | benzinga.comPhiladelphia-area life sciences firms have now cut more than 500 jobs since the start of 2022September 6, 2023 | bizjournals.com Get LAVA Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LAVA and its competitors with MarketBeat's FREE daily newsletter. Email Address LAVA Media Mentions By Week LAVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LAVA News Sentiment▼0.001.20▲Average News Sentiment LAVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LAVA Articles This Week▼00▲LAVA Articles Average Week Get LAVA Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LAVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LAVA) was last updated on 6/29/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics NV Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LAVA Stock Free LAVA Stock Alerts